Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02940431 · ClinicalTrials.gov registry record · NA
Active Games: Increasing the Attractiveness of Active Video Game Play for Youth
A NA study, sponsored by USDA Grand Forks Human Nutrition Research Center.
- Completed
- Registry status
- NA
- Development phase
- 49
- Enrollment target
NCT02940431: Completed NA study, sponsored by USDA Grand Forks Human Nutrition Research Center.
NCT02940431 is a NA study that has completed, run by USDA Grand Forks Human Nutrition Research Center. The registered enrollment target is 49 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02940431, a NA study, has completed, sponsored by USDA Grand Forks Human Nutrition Research Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 49 participants
- Enrollment target
Study Summary
The purpose of this study is to look at the effects of active video game play on youth physical activity.
Primary Outcome
RRV of active video games will be assessed by evaluating the number of responses (mouse button presses) a participant is willing to complete to gain access to active video game play or an alternative (sedentary video game or traditional active play).
Interventions
- OTHER High Autonomy
- OTHER Low Autonomy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 49 participants |
| Start Date | 2016-11 |
| Est. Completion | 2018-05-04 |
| Phase | NA |
What the finished NCT02940431 record still lists
NCT02940431 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 49 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 2 interventions - of which High Autonomy is the first listed.
NCT02940431 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02940431 about?
NCT02940431 is a clinical study titled "Active Games: Increasing the Attractiveness of Active Video Game Play for Youth". The purpose of this study is to look at the effects of active video game play on youth physical activity.
What is the current status of trial NCT02940431?
This trial is currently completed. It is a NA study. The enrollment target is 49 participants. The study started on 2016-11. Estimated completion is 2018-05-04.
What interventions are being tested in trial NCT02940431?
The interventions under investigation include: High Autonomy (OTHER), Low Autonomy (OTHER).
Who is sponsoring clinical trial NCT02940431?
This trial is sponsored by USDA Grand Forks Human Nutrition Research Center, which has 57 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02940431's enrollment target sits among peer trials
49 1379th of 2000 higher than 620 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02704858 · 49 participants · Phase 1
Safety and Efficacy Study in Recurrent or Progressive Grade III or IV IDH1 Mutated Glioma
- NCT03516708 · 49 participants · Phase 1
Epacadostat (INCB024360) Added to Preoperative Chemoradiation in Patients With Locally Advanced Rectal Cancer
- NCT03692429 · 49 participants · Phase 1
alloSHRINK - Standard cHemotherapy Regimen and Immunotherapy With Allogeneic NKG2D-based CYAD-101 Chimeric Antigen Receptor T-cells
- NCT04329494 · 49 participants · Phase 1
PIPAC for the Treatment of Peritoneal Carcinomatosis in Patients With Ovarian, Uterine, Appendiceal, Colorectal, or Gastric Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia